From the Editor

Paul, Reid
January 2011
Pharmaceutical Representative;Jan2011, Vol. 41 Issue 1, p5
The article presents a message from the journal's editor which discusses the role of pharmaceutical representatives in the industry. He mentions the statement of the journal's founding publisher William M. McKnight regarding its contribution to the industry and not merely for advertising purposes. He expresses his gratitude to the writers of the journal for providing pharmaceutical representatives in the U.S. with useful information.


Related Articles

  • Flexing Their Budgets. Brichacek, Andra; Sellers, L.J. // Pharmaceutical Executive;Sep2001, Vol. 21 Issue 9, p78 

    Discusses trends in marketing budgets in the pharmaceutical industry. Role of sales personnel in promotional spending; Value of the spending by pharmaceutical companies for meetings and events; Report on the growth of journal advertising.

  • The final countdown. Warner, K. C. // Pharmaceutical Representative;Apr2008, Vol. 38 Issue 4, p37 

    The article focuses on the importance of decision making in product launching. The author states that launching is the culminating of years of research and planning that may ultimately change the pharmaceutical landscape forever. He implies that advertisement and media press releases that fuel...

  • Through the side door. Laberge, Ananda // Pharmaceutical Representative;Jul2006, Vol. 36 Issue 7, p30 

    The article reports on the challenges faced by sales representatives in the pharmaceutical industry in the U.S. One of the more difficult challenges which representatives face in the era of restricted pharmaceutical selling is the closed hospital. However, this issue is not as daunting as what...

  • If a tree falls …. Edwards, Jim // Pharmaceutical Representative;Oct2007, Vol. 37 Issue 10, p26 

    The article offers tips on how to become an effective emotion-based sales personnel in the pharmaceutical industry.

  • Hard at work.  // Pharmaceutical Representative;Aug2007, Vol. 37 Issue 8, p3 

    The article discusses various reports published within the issue including one by Marjorie Brody on becoming a good pharmaceutical sales representative, and another by Sharon L. Marshall on the pros and cons of contract sales.

  • Surveys question efficiency of expanded field forces in accessing and selling doctors.  // Medical Marketing & Media;Feb2000, Vol. 35 Issue 2, p18 

    Reports that two studies are questioning whether the premise and productivity of expanded sales forces of pharmaceutical companies in the United States bring expected returns. Study by Health Strategies Group which revealed that a large percentage of sales calls to high prescribers allow less...

  • When Will the Bubble Burst? Goldberg, Michele; Davenport, Bob; Mortellito, Tiffany // Pharmaceutical Executive;Jan2003, Vol. 23 Issue 1, p44 

    Discusses the 2002 compensation module of the Hay Group's annual Sales Force Effectiveness Study for the pharmaceutical industry. Percentage of companies that expanded their sales forces; Slowdown in the use of contract sales organizations; Pressure on company recruiters to hire additional...

  • Takes one to know one: reps choose top sales forces, tell what makes them tick.  // Medical Marketing & Media;Jun2000, Vol. 35 Issue 6, p6 

    Reports on the top pharmaceutical companies in terms of effectiveness of sales forces. Sales representatives' ranking of the companies; Pfizer; Merck; Bristol-Myer; Glaxo Wellcome; SmithKline Beecham; Eli Lilly.

  • Should you see a drug rep calling on spec? Moore, Peter // Pulse;11/3/2003, Vol. 63 Issue 44, p72 

    Advises physicians on how to deal with visits by pharmaceutical sales representatives. Proper approach to the pharmaceutical industry; Appropriateness of seeing a sales agent without an appointment; Belief on the evidence presented by sales agents; Guidelines followed by drug companies.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics